Arrowhead Research | Efectivo Y Equivalentes

Cash And Equivalent Cambio Fecha
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
Incyte USD 3.21B 13.85M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Ligand Pharmaceuticals USD 22.95M 3.68M 2023-12
Merck USD 8.6B 2.94B 2023-09
Moderna USD 2.91B 25M 2023-12
Sarepta Therapeutics USD 541.93M 310M 2023-09
TG Therapeutics USD 217.51M 66.61M 2023-12
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09
Xencor USD 53.79M 1.06M 2023-12



Arrowhead Research Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.